Aurobindo Pharma Limited — Others, 13-12-2024: Action(s) initiated or orders passed

Aurobindo Pharma has received an order from the Additional Commissioner, Appellate Authority, in Andhra Pradesh, demanding a reversal of Input Tax Credit (ITC) totaling ₹5.69 crore, along with interest of ₹4.80 crore and a penalty of ₹0.57 crore, amounting to a total dispute of ₹11.05 crore for the financial years 2017-20. The company plans to appeal this decision. Although this order appears significant, management indicates there will be no material impact on financials or operations. Investors should monitor potential risks from the appeal process, but the outlook remains stable for now.